Akili Inc   (AKLI)
Other Ticker:  
Price: $0.2216 $0.00 -0.045%
Day's High: $0.2321 Week Perf: -7.67 %
Day's Low: $ 0.19 30 Day Perf: -20.86 %
Volume (M): 347 52 Wk High: $ 2.08
Volume (M$): $ 77 52 Wk Avg: $0.88
Open: $0.23 52 Wk Low: $0.19

 Market Capitalization (Millions $) 17
 Shares Outstanding (Millions) 78
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -109
 Cash Flow (TTM) (Millions $) -16
 Capital Exp. (TTM) (Millions $) 0

Akili Inc
Akili Inc is a digital medicine company that is focused on developing clinically-validated prescription treatments using video game technology. They create interactive entertainment experiences designed to target specific cognitive systems in the brain. These digital therapies are aimed at addressing various medical conditions and improving neurological conditions. Akili's products have been successfully used in clinical trials and show potential in treating conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The company is at the forefront of the emerging field of digital therapeutics, utilizing innovative technology to provide novel treatment options.

   Company Address: 125 Broad Street Boston 2110 MA
   Company Phone Number: 456-0597   Stock Exchange / Ticker: NASDAQ AKLI
   AKLI is expected to report next financial results on March 08, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Akili Inc

Despite revenue surge, Medical Equipment & Supplies Company struggles to achieve profitability at Akili Inc in Q3 2023

Akili Inc, a medical equipment and supplies company, announced a remarkable increase in revenue for the third quarter of 2023. Their revenue surged by 756.098% year on year to $0.70 million, outperforming their industry peers who achieved an average top-line growth of 4.89% in the same period. This improvement in revenue also represents a significant advancement from the preceding quarter, where Akili Inc experienced a shortfall of $-0.15 per share and doubled their revenue by 515.789% to $0.11 million.
However, despite the positive revenue growth, Akili Inc recorded a shortfall per stock of $-0.20. This shortfall indicates that the company's expenses exceeded their revenue during the mentioned period.

Akili Inc

Akili Inc Announces Revenue of $0.114 Million, Demonstrating Steady Growth and Market Expansion Potential

Akili Inc: A Bullish Outlook on Strong Market Performance
In a recent announcement, Akili Inc revealed its revenue for the most recent fiscal period, amounting to $0.114 million. This figure showcases steady growth and an opportunity for the company to expand its market presence further. While it is important to note that the net deficit was reported at $-11.759 million, larger than the previous year?s $-1.734 million, it's crucial to understand the factors behind this increase.
Looking ahead, investors and analysts anticipate the next financial earnings report, scheduled to be released on November 13, 2023. This eagerly awaited event will shed more light on the company's financial performance and its trajectory for the future. However, it is crucial to assess the company's broader market performance to better comprehend the impact of these results.

Akili Inc

Akili Inc.'s Q1 2023 Financial Performance Highlights Concerns for the Company's Future

Akili Inc. has recently released its Q1 2023 financial results, and it does not bode well for the company's future. The company generated a mere $0.113 million in revenue for the quarter, a steep decline compared to its previous year's numbers. But what's even more concerning is the fact that the company recorded a net loss of $-20.711 million. This is a significant increase from the $-4.176 million net loss it reported in the same quarter last year.
This news is not a good sign for investors who have put their money into Akili Inc. The company's failure to generate revenue implies that it may not be able to sustain itself for much longer. Furthermore, the higher net loss for the quarter indicates that management hasn't been able to keep costs under control and reduce expenses.


Akili Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com